Purification and structural analyses of ABCG2

被引:24
作者
McDevitt, Christopher A. [1 ]
Collins, Richard [2 ]
Kerr, Ian D. [3 ]
Callaghan, Richard [1 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England
[2] Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England
[3] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Ctr Biochem & Cell Biol, Nottingham NG7 2UH, England
关键词
Multidrug resistance; Multidrug efflux; Membrane protein solubilisation; Electron microscopy; Oligomerisation; Molecular modelling; Structural analysis; CANCER RESISTANCE PROTEIN; HUMAN MULTIDRUG TRANSPORTER; P-GLYCOPROTEIN; ATP-BINDING; SIDE-POPULATION; GEL-FILTRATION; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; TRANSMEMBRANE DOMAINS; LACTOCOCCUS-LACTIS;
D O I
10.1016/j.addr.2008.07.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
ABCG2 is best known as a multidrug transporter capable of conferring resistance to cancer cells. However, the protein is also inherently expressed in numerous barrier tissues and intriguingly within hematopoietic stem cells. Unlike its partners ABCB1 and ABCC1, there is considerably less information available on the molecular mechanism of ABCG2. The transporter has a distinct topology and is presumed to function as a homodimer. However, a number of biochemical studies have presented data to suggest that the protein adopts higher order oligomers. This review focuses on this controversial issue with particular reference to findings from low resolution structural data. In addition, a number of molecular models of ABCG2 based on high resolution structures of bacterial ABC transporters have recently become available and are critically assessed. ABCG2 is a structurally distinct member of the triumvirate of human multidrug transporters and continues to evade description of a unifying molecular mechanism. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:57 / 65
页数:9
相关论文
共 81 条
[1]   Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding [J].
Alqawi, O ;
Bates, S ;
Georges, E .
BIOCHEMICAL JOURNAL, 2004, 382 (02) :711-716
[2]   ESTIMATION OF MOLECULAR WEIGHTS OF PROTEINS BY SEPHADEX GEL-FILTRATION [J].
ANDREWS, P .
BIOCHEMICAL JOURNAL, 1964, 91 (02) :222-+
[3]   Oligomerization of the human ABC transporter ABCG2:: Evaluation of the native protein and chimeric dimers [J].
Bhatia, A ;
Schäfer, HJ ;
Hrycyna, CA .
BIOCHEMISTRY, 2005, 44 (32) :10893-10904
[4]   High throughput protein production for functional proteomics [J].
Braun, P ;
LaBaer, J .
TRENDS IN BIOTECHNOLOGY, 2003, 21 (09) :383-388
[5]   ATPase activity of purified multidrug resistance-associated protein [J].
Chang, XB ;
Hou, YX ;
Riordan, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30962-30968
[6]   A tweezers-like motion of the ATP-binding cassette dimer in an ABC transport cycle [J].
Chen, J ;
Lu, G ;
Lin, J ;
Davidson, AL ;
Quiocho, FA .
MOLECULAR CELL, 2003, 12 (03) :651-661
[7]   Expression of 25 human ABC transporters in the yeast Pichia pastoris and characterization of the purified ABCC3 ATPase activity [J].
Chloupkova, Maja ;
Pickert, Amanda ;
Lee, Jyh-Yeuan ;
Souza, Shiloe ;
Trinh, Yenphuong T. ;
Connelly, Sara M. ;
Dumont, Mark E. ;
Dean, Michael ;
Urbatsch, Ina L. .
BIOCHEMISTRY, 2007, 46 (27) :7992-8003
[8]   Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter [J].
Clark, R. ;
Kerr, I. D. ;
Callaghan, R. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (05) :506-515
[9]   The Q-loop disengages from the first intracellular loop during the catalytic cycle of the multidrug ABC transporter BmrA [J].
Dalmas, O ;
Orelle, C ;
Foucher, AE ;
Geourjon, C ;
Crouzy, S ;
Di Pietro, A ;
Jault, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (44) :36857-36864
[10]   Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP [J].
Dawson, Roger J. P. ;
Locher, Kaspar P. .
FEBS LETTERS, 2007, 581 (05) :935-938